Regeneron buying 23&Me for $256M. Regeneron is one of a few companies that can extend the value of this data. Will they continue to operate 23&Me or just ingest the data and shutter them? And has anyone verified that the “deleted” user data was actually deleted?

If you have an answer already, maybe it just takes that long to make the data fit?

The court in Texas just vacated the FDA Lab developed test (LDT) rule in a lawsuit brought by the ACLA and AMP. www.amp.org/AMP/assets/F...

23&Me files for bankruptcy. If you are a customer, it would be wise to delete your data. Here are the steps. Log in, Go to “settings” section of your profile. Scroll to a section labeled “23andMe data” at the bottom of the page. Click “view” next to “23andMe data.”

This letter appeared in the Bloomsburg PA Press Enterprise this morning. I am assured the writer is who he purports to be, an Air Force veteran.

It’s true. For all the good vibes here, engagement kinda sucks.

Following the Roche SBX announcement, a question: In 2012, Roche tried to acquire Illumina for $6.8B but failed, so they built their own sequencer over 10 years for likely less. Smart move or should they have bought Illumina for an extra $1B in 2012? Thoughts?

Famous moments in recent history: Aug 2nd, 1914 - Luxembourg invades Germany. Sep 1st, 1939 - Poland starts WW2. Dec 7th, 1941 - US aggression against Japan. Jun 25th, 1950 - South Korean troops cross the 38th Parallel. Dec 25th, 1979 - Afghanistan invades the USSR. Feb 24th, 2022 - 'nuff said!

For anyone weighing in on the NIH decision to cap indirect costs at 15%, I strongly recommend watching the video to gain at least a basic understanding of indirect costs before forming an opinion and commenting. m.youtube.com/watch?v=1XvV...

1. Today the NIH director issued a new directive slashing overhead rates to 15%. I want to provide some context on what that means and why it matters. grants.nih.gov/grants/guide...

If this policy stays in place, the consequences the consequences for life science research across the United States could be far reaching.

Quanterix's acquisition of Akoya is interesting and highlights signs of contraction (Nanostring, Fluent) in the spatial biology and single-cell markets. With many companies struggling for market share and profitability, more consolidations may follow. tinyurl.com/bdehzbd3

Warum ist Deutschland bei Suchtprävention und Gesetzgebung hinter den meisten westlichen Staaten? Z.B. beim Rauchen und leider auch beim Alkohol. Der Stand der Wissenschaft ist eindeutig. Jede Zigarette und jeder Tropfen Alkohol sind schlecht für die Gesundheit. www.spiegel.de/gesundheit/a...

The origins of GFP with a somewhat tragic origin story (if you are a young scientist).

The problem with antibodies that have not been properly validated. This may only be the tip of the iceberg. I hope the spatial biology field takes note. For a good review of the problem check out this news feature www.nature.com/articles/521... Entrop et al. www.nature.com/articles/s41...

If you ever stayed with family or friends over the holidays and they didn’t own a mansion, check out this thread. Enjoy!

Saw this link posted on LI to a reddit group “What’s the worst biotech company you’ve worked for?”. Interesting which companies get multiple entries. www.reddit.com/r/biotech/co...

A pattern emerges… www.genomeweb.com/sequencing/o...

Want to be connected to people that are experts in Genomics? ⬇️

I sad it before and I say it again. De-index MDPI and Frontiers (maybe minus anything that is not garbage) and it will get better.

Rehashed and disproven conspiracy theories from the late 90s? Here you go… news.immunologic.org/p/viruses-ar...

Has anybody here blocked followers? On Twitter it was fairly obvious who the bots and trolls were. Do they exist on this platform too? Or not yet?

@catharineaquino.bsky.social helping us to connect over here.

Celebrating 10 years of my first ever review article in the field of Extracellular Vesicles #ExtracellularVesicles and that in NatureReviews 🥳. lnkd.in/ddbrUmEA .

I wonder how many academics and life science companies have started contemplating how the next four years might unfold, for example in terms of NIH funding.

Want to know why durable weight loss is so difficult? It’s the epigenetic memory. How can we get epigenetic amnesia?

We strongly suggest that academic publishers and other platforms that host research rapidly implement a Share to Bluesky button for their articles. Here's how: docs.bsky.app/docs/advance... #AcademicSky #HigherEd #Altmetrics

Dr. Oz will be running Centers for Medicare & Medicaid Services (CMS). www.reuters.com/world/us/tru...

Bluesky tip for newbies: Bluesky has no real algorithm. Likes here do nothing but show the poster that you enjoyed their content. That kindness is always going to be appreciated by creators, but if you want to help to boost something here, you have to repost it so others see it. 🙂

It’s not even Thanksgiving yet. No Boston Airport, just no.

Science Twitter is back on BlueSky, and better. Impressive how fast this happened. Mastodon never seemed like a viable alternative. Elmo is doing a great job bringing Science communities together.

Reminder for newcomers that bioRxiv has Bluesky accounts in every subject category - great way to keep up (please re-skeet) connect.biorxiv.org/news/2023/09...

Is Ultima Genomics $100 genome on a $1.5M instrument truly game changing? Does this crazy hype cycle serve the company in the long run? Asking for a friend…